Afore Capital: The $500M Pre-Seed Fund That Backs Founders Before They Have an Idea

In February 2025, Afore Capital closed its fourth fund at $185 million, crossing $500 million in total assets under management. That is a remarkable number for a firm that bets exclusively at pre-seed, where most companies don't yet have a product, revenue, or sometimes even a legal entity. If you want to understand where institutional capital is moving before angels see the deal flow, you need to understand what Afore is doing and why it works.

What Afore Actually Does

Afore Capital writes checks at day zero. The firm defines pre-seed as the moment before a company has demonstrated product-market fit, often before it has shipped anything at all. Under Fund IV, that means checks ranging from $50,000 to $2 million, with the firm leading more than 80 percent of the rounds it enters. The fund is sector-agnostic: the portfolio spans SaaS, AI infrastructure, developer tools, fintech, healthcare, consumer marketplaces, and even hardware. The unifying thread is not the category. It is the founder.

Afore's prior standard product, called Afore Alpha, wrote a $1 million check via a SAFE at a $10 million post-money valuation, a clean 10 percent equity stake with no ambiguity. That standardized structure was designed to shorten the fundraising cycle for founders who couldn't afford to spend 90 days on investor meetings. As Banerji noted when the structure launched: "Raising $125,000 means founders have to raise in 90 days guaranteed. How can that be the best option?" Under Fund IV, the firm shifted to flexible check sizes it calls Pre-Seed 2.0, arguing that a fixed structure sometimes harmed founders by forcing them to take more or less capital than the moment required. The flexibility is a direct response to what the fund learned across 200-plus portfolio companies.

With Fund IV, Afore plans to back 35 to 40 pre-seed companies and another 50 to 75 founders through its Founders-in-Residence program (more on that below). The collective portfolio across all four funds sits at a $13.5 billion valuation.

The Fund History at a Glance

Fund	Year Closed	Size	Focus / Notes
Fund I	2017	$47M	Debut fund, 38 portfolio companies, returned 1x+ to LPs by early 2025
Fund II	2019	$77M	Likely largest dedicated pre-seed fund at the time, checks $500K-$1M
Fund III	2022	$150M	Introduced Afore Alpha standard deal, claimed ~25% of all pre-seed dollars raised industry-wide
Fund IV	2025	$185M	Pre-Seed 2.0 flexible model, $50K-$2M checks, FIR program expanded, self-described world's largest pre-seed fund

The Founders Behind the Firm

I pay close attention to GP backgrounds at pre-seed funds because conviction at that stage has almost nothing to do with financial modeling. You are betting on people, not spreadsheets. Afore's two co-founders have credentials that matter here.

Anamitra Banerji was employee number 30 at Twitter, joining in March 2009 as the company's first product manager. He built Twitter's advertising platform from scratch. That product eventually became the firm's primary revenue engine. After Twitter, he joined Foundation Capital as a partner, where he made SaaS and consumer investments before co-founding Afore in 2016. His pattern recognition for early-stage product builders comes from having been one himself at a company that went from 30 employees to a global platform.

Gaurav Jain was Android's first product manager at Google, where he received the company's Founders Award for his work on the Nexus product line. Before Google, he co-founded Polar Mobile, raised capital, and grew the company to more than 50 employees before selling. After Google, he joined Founder Collective as a principal and made 26 seed investments, including Cruise Automation (acquired by GM for more than $1 billion) and Firebase (acquired by Google). He holds an MBA from Harvard Business School. His edge at pre-seed is simple: he has been a founder, a PM at a platform-defining product, and an early-stage investor. He knows what the first 18 months of building actually looks like from all three seats.

Both partners look for the same thing. Banerji describes it as searching for "gold versus bronze." The question is not whether the current idea is right, but whether the founder has the judgment to find the right idea. "We would want to invest in amazing founders who we believe will get to the right idea eventually, or we can help them get to the right idea," Banerji told The Peel podcast. That framing explains the firm's willingness to write a term sheet before a legal entity exists.

What the Track Record Actually Shows

Five unicorns from a single pre-seed fund is not a number you should dismiss. Afore's portfolio includes Gamma (the AI presentation tool, now at a $2.1 billion valuation with 70 million users and $100 million in annual recurring revenue), Hightouch ($1.2 billion, data warehouse activation for marketing teams), Modern Health ($1.17 billion, B2B mental wellness), BetterUp ($4.7 billion peak valuation, executive coaching), and Neo Financial (Canadian neobank, valuation undisclosed).

The $1.2 billion Hightouch outcome deserves a closer look. Afore participated in Hightouch's original $2.1 million pre-seed round alongside the Slack Fund when the founders were still exploring a "ChatGPT for travel" concept. The pivot to data activation for marketing teams came after that check. Afore stayed in. Total capital raised reached $172 million across four rounds.

On the acquisition side, Afore has logged 18 exits total. BenchSci (AI drug discovery, $215 million raised through Series D) was the firm's very first investment, made from Fund I in 2017. Pomelo, the remittance fintech serving US immigrants sending money to the Philippines, was acquired by Zepz in January 2026 after raising a $35 million Series A in 2024. Kubecost, a Kubernetes cost management tool, was acquired by IBM in September 2024.

The portfolio-level numbers are worth stating plainly. For every dollar Afore invests, $39 in follow-on capital has followed its companies. Eighty-five percent of portfolio companies raise institutional follow-on rounds. And 64 percent of Fund I and Fund II companies skipped the seed round entirely and went straight to Series A, a signal that later-stage institutional investors viewed Afore-backed companies as past the earliest risk threshold.

The DPI story matters too. Despite an industry-wide VC downturn, Afore returned more than 1x of its $47 million Fund I to LPs within a six-month window before the February 2025 Fund IV close. That is actual cash in LP hands, not paper marks.

Pre-Seed 2.0 and the Gamma Co-Fund

The most interesting structural move Afore has made recently is the "Ideas to Reality Fund," a $10 million vehicle co-branded with Gamma, one of its portfolio companies. The fund backs up to 10 pre-seed teams at up to $1 million each, with no product required at the time of investment. Applications closed in March 2026.

Think about what that structure signals. A portfolio company (Gamma, $2.1 billion, $100 million ARR) is co-investing with its original pre-seed backer to find the next generation of founders. The incentives align: Gamma gets early access to teams that might build on or alongside its platform. Afore gets deal flow filtered through a successful operator. Laura Du, an Afore principal who was an intern at the firm when Gamma was just an idea five years ago, is the lead on the vehicle. The structure is not a gimmick. It is Afore testing whether the value-creation loop it built for founders can extend to the portfolio company level.

The Founders-in-Residence program follows similar logic. Afore brings in five to eight founders per cohort for an eight-week program focused on idea generation, not pitch practice. Gaurav Jain put it directly: "The goal is to invent. The goal is to build. The goal is not to fundraise." More than 50 companies have come through six cohorts. Some, like Openmart (AI sales intelligence for local businesses), went on to Y Combinator after completing the FIR program. Afore writes the initial check before a product exists.

What This Means for Angel Investors

Here is where I want to be direct with you about what Afore's model means for where you should be deploying your own capital.

Afore occupies the institutional pre-seed slot, typically $250,000 to $2 million on a SAFE at valuations between $8 million and $15 million post-money. That is the round that comes right before seed. If you are an angel writing $25,000 to $100,000 checks, you are almost always participating in the same round as Afore or coming in at the friends-and-family stage before Afore arrives. You are not competing with Afore. You are potentially co-investing alongside it.

The Afore portfolio also gives you a signal list. When a company raises a pre-seed from Afore, the historical data says 85 percent will raise an institutional follow-on. If you see an Afore-backed company opening a seed round, that context matters. It does not guarantee success. Nothing does at this stage. But it tells you a firm with a $500 million track record made a conviction bet early.

Where angels should focus is the stage before Afore arrives: the friends-and-family round, the $50,000 to $200,000 that helps a founder get to the point where an Afore conversation makes sense. That is where your informational edge as a domain expert, operator, or connector can actually beat an institutional firm's process. Afore backs 35 to 40 companies per fund. There are thousands of pre-seed companies formed each year. Your network is your edge at the earliest stage — their capital is the amplifier that follows.

The Honest Caveat

Pre-seed is still the highest-loss stage in venture capital, regardless of manager quality. Afore has produced unicorns and returned Fund I. It has also made bets that did not work out. The firm does not publicize its loss rate, and no pre-seed investor should claim otherwise. When you back a founder before they have a product, a customer, or a tested hypothesis, you are making a bet on human judgment under extreme uncertainty. Most of those bets fail.

The 39x follow-on multiplier and the 85 percent follow-on rate are genuine signals that Afore is selecting better than average. But "better than average" at pre-seed still means a large portion of investments return nothing. The Fund I DPI milestone, returning more than $47 million to LPs, came from a small number of winners in a 38-company portfolio. That is how venture math works. Understand that before you treat any pre-seed track record as a guarantee of future performance.

Afore's SEC registration (CRD 285601) is public. Their Form ADV was last updated March 24, 2026. Read it if you are evaluating any co-investment opportunity alongside the firm. The regulatory filings give you the most accurate picture of reported AUM and any material disclosures.

If you are building a pre-seed angel portfolio, Afore Capital is the clearest benchmark to study. Watch their portfolio announcements. Track which companies they back. And be honest with yourself about the loss rates you are taking on when you invest at the same stage.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.